The Dubai Health Annual Report is now available.
Click here
to read our story.
x
Consultant , Endocrinology
Dr. Jalal Nafach
Languages
Consultation Type
What this doctor can help you with:
Practices At
Overview
Overview
Experience
Dubai Health
United Arab Emirates
2012 - PresentEndocrine Consultants Of Nebraska
United States
2002 - 2012Education
Board - Diplomate American Board of Endocrinology, Diabetes and Metabolism
American Board of Medical Specialties, United States of America
Fellowship - Clinical Fellowship in Endocrinology, Diabetes and Metabolism
University Of Nebraska, United States of America
Board - Diplomate American Board of Internal Medicine
American Board of Medical Specialties, United States of America
Residency - Internal Medicine
McLaren Health Care, United States of America
Medical School - Doctor of Medicine (MD)
Damascus University, Syria
Research and Publication
-
Real-World Assessment of Efficacy and Safety Parameters for Dapagliflozin in Management of Type 2 Diabetes Mellitus: REWARD Study
See the article
-
Liraglutide as Add-on to Sodium-glucose Co-transporter-2 Inhibitors in Patients with Inadequately Controlled Type 2 Diabetes: LIRA-ADD2SGLT2i, a 26-week, Randomized, Double-blind, Placebo-controlled Trial
See the article
-
Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in United Arab Emirates Patients with Type 2 Diabetes
See the article